Breast cancer awareness month: turning awareness into action

Breast cancer remains one of the most common cancers worldwide, affecting millions of women each year.¹ Yet, survival rates continue to improve, thanks to one critical factor: early detection.

Early detection isn’t just a catchphrase; it’s a clinical game changer. Identifying cancer at its most treatable stage leads to less invasive treatments, lower mortality rates and better quality of life. Mammography has been the cornerstone of early detection for decades, and its evolution is nothing short of remarkable.

Traditional 2D mammography has saved countless lives, but advancements like digital breast tomosynthesis (DBT), or 3D mammography, have taken imaging to the next level. By providing detailed, layered views of breast tissue, DBT makes it easier to detect subtle lesions, especially in dense breast tissue.

At Philips, we’re focused on seamlessly integrating these innovations into clinical workflows. By reducing variability, enhancing accuracy and enabling faster, more confident decisions, we’re empowering radiologists to deliver better outcomes. When paired with AI-powered image analysis, mammography can now identify patterns and anomalies that were once invisible to the human eye.²

This precision isn’t just about finding more cancers – it’s about finding the right ones earlier, with greater consistency and fewer unnecessary follow-ups. That’s how we improve both outcomes and patient experience.

While mammography remains the frontline tool for screening, breast MRI has emerged as a vital complement, particularly for women at higher risk. With its superior sensitivity, MRI excels at detecting invasive cancers that mammography might miss.³

For women with dense breast tissue or a family history of breast cancer, MRI offers a critical advantage. And thanks to new protocols and AI-enhanced reconstruction techniques, MRI is becoming faster, more comfortable and more accessible.

We’re also seeing a convergence of imaging modalities – mammography, ultrasound and MRI – into integrated diagnostic environments. This holistic approach supports radiologists, oncologists and surgeons in delivering precise, patient-centered care.

The future of breast care isn’t just about sharper imaging; it’s about smarter strategies. Every woman’s risk is unique, and technology is finally catching up to this reality.

Risk models like the Tyrer-Cuzick Score (IBIS model) quantify a woman’s lifetime risk of developing breast cancer based on factors like family history, genetics, breast density and lifestyle. When combined with advanced imaging, these insights enable clinicians to design personalized screening pathways – tailored to when to start imaging, how often and which modalities to use.

While no model is perfect, these tools are shifting the mindset from reactive to proactive care. Women who understand their risk can engage more deeply in their health, ask informed questions and make empowered decisions about screening and prevention.

Awareness today means more than knowing breast cancer exists – it means understanding your personal risk and knowing that early detection is within reach.

Artificial intelligence is revolutionizing radiology at an unprecedented pace. In breast imaging, AI assists with lesion detection, density assessment and workflow optimization –helping radiologists manage increasing case volumes without compromising quality.

But AI’s true potential lies in augmenting clinical judgment. By integrating data from imaging, pathology and genomics, AI creates a unified, comprehensive view of each patient’s health.⁴

At Philips, our mission is to ensure that every clinician, regardless of location, has access to tools that enable earlier, more accurate diagnoses. By combining human expertise with machine intelligence, we achieve the best of both worlds: the empathy and intuition of clinicians, supported by the precision and depth of AI.

When awareness evolves into action, and action is powered by compassion and technology, we create a system that truly works for women.

No single technology or modality can solve breast cancer alone. The key lies in integration – connecting imaging, data and expertise into a seamless care pathway.

From radiology to oncology, genetics to primary care, success depends on collaboration. At Philips, we’re uniquely positioned at this intersection, helping healthcare systems streamline workflows, reduce inefficiencies and improve diagnostic confidence through connected solutions.

By uniting imaging, informatics and AI, we’re making care more predictive, personalized and precise.

Breast Cancer Awareness Month has always been about visibility. Today, visibility takes on a new meaning – not just social awareness, but clinical visibility: the ability to detect, interpret and act on what’s happening inside the body earlier than ever before.

As a physician, I’ve witnessed how early detection saves lives. As a leader in clinical AI ecosystems, I’ve seen how collaboration between technology companies, clinicians and researchers accelerates progress in ways no single stakeholder could achieve alone.

This October, let’s push beyond the pink. Awareness is vital, but action is the ultimate goal:

At Philips, we believe that when innovation meets empathy, the future of women’s health becomes brighter. Together, we can make breast cancer a story of survival and strength.